Narnatumab


Narnatumab
Narnatumab ?
Monoclonal antibody
Type Whole antibody
Source Mouse
Target CD22
Clinical data
Pregnancy cat.  ?
Legal status  ?
Identifiers
CAS number 1188275-92-4 N
ATC code None
Chemical data
Formula C6454H10026N1754O2020S44 
Mol. mass 145.9 kDa
 N(what is this?)  (verify)

Narnatumab is a human monoclonal antibody designed for the treatment of cancer.[1]

Narnatumab was developed by ImClone Systems.

References

  1. ^ "Statement On A Nonproprietary Name Adopted By The USAN Council: Narnatumab". American Medical Association. http://www.ama-assn.org/resources/doc/usan/narnatumab.pdf.